| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.07 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.091 | 0.08 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |